Wimmer Associates 1’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.2M Buy
2,395
+85
+4% +$86.2K 1.08% 25
2025
Q4
$2.48M Buy
2,310
+86
+4% +$82.2K 1.15% 22
2025
Q3
$1.7M Sell
2,224
-45
-2% -$33.5K 0.82% 32
2025
Q2
$1.77M Buy
2,269
+3
+0.1% +$2.33K 0.9% 29
2025
Q1
$1.69M Buy
2,266
+66
+3% +$54.9K 0.89% 29
2024
Q4
$1.7M Buy
2,200
+815
+59% +$675K 0.84% 29
2024
Q3
$1.23M Sell
1,385
-7
-0.5% -$6.29K 0.6% 40
2024
Q2
$1.26M Buy
1,392
+25
+2% +$20K 0.65% 40
2024
Q1
$1.06M Hold
1,367
0.56% 47
2023
Q4
$797K Sell
1,367
-28
-2% -$16.3K 0.45% 52
2023
Q3
$749K Buy
1,395
+110
+9% +$56.7K 0.47% 52
2023
Q2
$603K Hold
1,285
0.36% 66
2023
Q1
$558K Buy
1,285
+85
+7% +$28.7K 0.36% 70
2022
Q4
$439K Sell
1,200
-40
-3% -$14.2K 0.29% 80
2022
Q3
$449K Sell
1,240
-5
-0.4% -$1.58K 0.3% 79
2022
Q2
$404K Buy
1,245
+45
+4% +$13.5K 0.26% 81
2022
Q1
$344K Sell
1,200
-210
-15% -$54K 0.19% 93
2021
Q4
$389K Hold
1,410
0.21% 90
2021
Q3
$326K Hold
1,410
0.19% 96
2021
Q2
$324K Hold
1,410
0.19% 97
2021
Q1
$263K Buy
1,410
+55
+4% +$10.8K 0.14% 100
2020
Q4
$229K Hold
1,355
0.14% 107
2020
Q3
$201K Buy
+1,355
New +$210K 0.14% 104

Other funds holding LLY

Wimmer Associates 1's LLY Position: Q1 2026 in Review

Wimmer Associates 1 increased its Eli Lilly (LLY) stake by 3.7% in Q1 2026, buying an estimated $86.2K and bringing the position to 2,395 shares worth $2.2M. The position accounts for 1.08% of the portfolio, ranked #25.

Wimmer Associates 1 first reported a position in LLY in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.48M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wimmer Associates 1 held 2,395 shares of Eli Lilly worth $2.2M as of Q1 2026.
  • Wimmer Associates 1 bought 85 Eli Lilly shares in Q1 2026, an estimated $86.2K.
  • Eli Lilly made up 1.08% of Wimmer Associates 1's portfolio in Q1 2026, its #25 holding.
  • Wimmer Associates 1 first reported a position in Eli Lilly in Q3 2020 and has held it in 23 quarters since.
  • Wimmer Associates 1's Eli Lilly position peaked at $2.48M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wimmer Associates 1's 13F filing for Q1 2026, filed 15 May 2026.